Biotech · Private company · New York, NY, US
Ceramedix Holding, LLC
Track this companyFree. Adds Ceramedix Holding, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards5
- Development of CX-03b as a Novel MCM for Treatment of GI-ARSFiscal year 2026 · $1.5MNIH RePORTER 75N93026C00007-0-9999-1 · fetched Nov 12, 2026
- Non-Clinical Pharmacology of CX-01Fiscal year 2025 · $993KNIH RePORTER 5R44AI106283-08 · fetched Nov 12, 2026
- DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSUREFiscal year 2025 · $1.3MNIH RePORTER 75N93023C00015-P00006-9999-1 · fetched Nov 12, 2026
- Non-Clinical Pharmacology of CX-01Fiscal year 2024 · $1MNIH RePORTER 5R44AI106283-07 · fetched Nov 12, 2026
- DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSUREFiscal year 2024 · $1.4MNIH RePORTER 75N93023C00015-P00003-9999-1 · fetched Nov 12, 2026